140 related articles for article (PubMed ID: 24289561)
1. Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus.
Ding J; Tang J; Chen X; Men HT; Luo WX; Du Y; Ge J; Li C; Chen Y; Cheng K; Qiu M; Liu JY
Asian Pac J Cancer Prev; 2013; 14(10):5675-80. PubMed ID: 24289561
[TBL] [Abstract][Full Text] [Related]
2. Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus.
Ding J; Li C; Tang J; Yi C; Liu JY; Qiu M
Pathol Oncol Res; 2016 Oct; 22(4):773-9. PubMed ID: 27138191
[TBL] [Abstract][Full Text] [Related]
3. The expression difference of insulin-like growth factor 1 receptor in breast cancers with or without diabetes.
Xin C; Jing D; Jie T; Wu-Xia L; Meng Q; Ji-Yan L
J Cancer Res Ther; 2015; 11(2):295-9. PubMed ID: 26148588
[TBL] [Abstract][Full Text] [Related]
4. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
Liao DW; Wang L; Zhang XG; Liu MQ
Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
[TBL] [Abstract][Full Text] [Related]
6. Expression characteristics of proteins of IGF-1R, p-Akt, and survivin in papillary thyroid carcinoma patients with type 2 diabetes mellitus.
Yan Y; Hu F; Wu W; Ma R; Huang H
Medicine (Baltimore); 2017 Mar; 96(12):e6393. PubMed ID: 28328831
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.
Kim JS; Kim ES; Liu D; Lee JJ; Solis L; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee HY
Clin Lung Cancer; 2014 May; 15(3):213-21. PubMed ID: 24485233
[TBL] [Abstract][Full Text] [Related]
8. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
[TBL] [Abstract][Full Text] [Related]
9. Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.
Kim JS; Kim ES; Liu D; Lee JJ; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee E; Lee HY
Oncotarget; 2015 Jun; 6(18):16746-56. PubMed ID: 25944691
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
[TBL] [Abstract][Full Text] [Related]
11. Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC).
Piper AJ; Clark JL; Mercado-Matos J; Matthew-Onabanjo AN; Hsieh CC; Akalin A; Shaw LM
PLoS One; 2019; 14(8):e0220567. PubMed ID: 31393907
[TBL] [Abstract][Full Text] [Related]
12. [Variation of insulin receptor substrate-2 gene 3'-untranslated region in patients with type 2 diabetes mellitus].
Zeng WM; Chen SH; Xie P; Liu ML; Song HP
Yi Chuan Xue Bao; 2003 Aug; 30(8):785-9. PubMed ID: 14682250
[TBL] [Abstract][Full Text] [Related]
13. Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib.
Morgillo F; Kim WY; Kim ES; Ciardiello F; Hong WK; Lee HY
Clin Cancer Res; 2007 May; 13(9):2795-803. PubMed ID: 17473213
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of EI24 confers resistance to gefitinib through IGF-1R signaling in PC9 NSCLC cells.
Choi JM; Jang JY; Choi YR; Kim HR; Cho BC; Lee HW
Lung Cancer; 2015 Nov; 90(2):175-81. PubMed ID: 26342551
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer.
Kim JS; Kim ES; Liu D; Lee JJ; Solis L; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee HY
Cancer; 2012 May; 118(9):2454-65. PubMed ID: 21952750
[TBL] [Abstract][Full Text] [Related]
16. mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes.
Liu R; Hu LL; Sun A; Cao YJ; Tang T; Zhang XP; Zhang QH
Arch Med Res; 2014 May; 45(4):318-24. PubMed ID: 24751329
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
18. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
19. Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung Cancer.
Xu X; Qiu Y; Chen S; Wang S; Yang R; Liu B; Li Y; Deng J; Su Y; Lin Z; Gu J; Li S; Huang L; Zhou Y
Curr Pharm Des; 2022; 28(25):2052-2064. PubMed ID: 36062855
[TBL] [Abstract][Full Text] [Related]
20. A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer.
Guo XF; Zhu XF; Cao HY; Zhong GS; Li L; Deng BG; Chen P; Wang PZ; Miao QF; Zhen YS
Oncotarget; 2017 Apr; 8(16):27286-27299. PubMed ID: 28460483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
